Abstract
Respiratory viral infections are major causes of morbidity and mortality in children with SCID and other primary immunodeficiencies who require BMT. Twenty-two of 73 (30%) such children were admitted with respiratory viral infections, of whom 13/22 (59%) died. All viruses were detected in nasopharyngeal aspirate (NPA). Virus was only found in BAL in those with LRTI. Eleven of 22 (50%) had paramyxovirus infections, all with severe viral pneumonitis which worsened post BMT. Five of 11 (45.5%) survived overall. All 11 received aerosolised ribavirin; five of 11 received additional inhaled immunoglobulin and corticosteroid. Three of 5 (60%) survived compared with two of six (33.3%) not thus treated. Three of 22 (13.6%) had adenoviruses; one died of disseminated disease, including pneumonia despite intravenous ribavirin. Eleven patients had rhinovirus detected; nine of 11 (82%) were asymptomatic or coryzal and survived. Two patients with additional severe lung pathologies had LRT rhinovirus and died. All patients received intravenous immunoglobulin. No treatments resulted in viral clearance without successful T cell engraftment. Respiratory viruses, particularly paramyxoviruses and adenoviruses are common, significant pathogens in these patients, significantly worsening outcome of BMT. NPA is an ideal specimen for diagnosis and monitoring of infection. Aggressive treatments may reduce viral replication and damage. Nebulised immunoglobulin and corticosteroid in LRTI may improve respiratory function and outcome. Bone Marrow Transplantation (2000) 26, 1097–1102.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fischer A, Landais P, Friedrich W et al. European experience of bone marrow transplantation for severe combined immunodeficiency Lancet 1990 336: 850–854
Crooks B, Cant A, Abinun M et al. Combination therapy for post-bone marrow transplant pneumonitis. In: 2nd Annual Spring meeting of the Royal College of Paediatrics and Child Health 1998 York, UK 1998 p 94
Rosen F, Wedgewood R, Eibl M et al. Primary immunodeficiency diseases: report of a WHO Scientific Group Clin Exp Immunol 1998 112: (Suppl. 1) 1–28
Gardener P, McQuillin J . Rapid Virus Diagnosis: Application of Immunofluorescence Butterworth: London 1974
Prince G, Porter D . Treatment of parainfluenza type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid J Infect Dis 1996 173: 598–608
Rimensberger P, Schaad U . Clinical experience with aerosolised immunoglobulin treatment of respiratory syncytial virus infection in infants Pediatr Infect Dis J 1994 13: 328–330
Taylor C, Osman H, Turner A et al. Parainfluenza virus and respiratory syncytial virus infection in infants undergoing bone marrow transplantation for severe combined immunodeficiency Commun Dis Public Health 1998 1: 202–203
Berrington J, Flood T, Abinun M et al. Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency Arch Dis Child 2000 82: 144–147
Krilov L, Pierik L, Keller E et al. The association of rhinoviruses with lower respiratory tract disease in hospitalized patients J Med Virol 1986 19: 345–352
Hierholtzer J . Adenoviruses in the immunocompromised host (review) Clin Microbiol Rev 1992 5: 262–274
McCarthy A, Bergin M, Silva LD, Stevens M . Intravenous ribavirin therapy for disseminated adenovirus infection Pediatr Infect Dis J 1995 14: 1003–1004
Wulffraat N, Geelen S, Dijken Pv et al. Recovery from adenovirus pneumonia in a severe combined immunodeficiency patient treated with intravenous ribavirin Transplantation 1995 59: 927
Groothuis J, Simoes E, Levin MJ et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children New Engl J Med 1993 329: 1524–1530
DeVincenzo J, Leombruno D, Soiffer R, Siber G . Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation Bone Marrow Transplant 1996 17: 1051–1056
Harrington R, Hooton T, Hackman R et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center J Infect Dis 1992 165: 987–993
McColl M, Corser R, Bremer J, Chopra R . Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin Bone Marrow Transplant 1998 21: 423–425
Ljungman P . Respiratory virus infections in bone marrow transplant recipients: the European perspective Am J Med 1997 102: 44–47
Wendt C, Weisdorf D, Jordan C et al. Parainfluenza virus respiratory infection after bone marrow transplantation New Engl J Med 1992 326: 921–926
Hemming V, Prince G, London W et al. Topically administered immunoglobulin reduces respiratory syncytial virus shedding in owl monkeys Antimicrob Agents Chemother 1988 32: 1269–1270
Piazza F, Johnson S, Ottolini M et al. Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small particle aerosol generator J Infect Dis 1992 166: 1422–1424
Ottolini M, Hemming V, Piazza F et al. Topical immunoglobulin is an effective therapy for P13 in a cotton rat model J Infect Dis 1995 172: 243–245
Crooks B, Taylor C, Turner A et al. Clinical experience of respiratory viral infections in children undergoing bone marrow transplantation for primary immunodeficiencies Bone Marrow Transplant 1999 23: (Suppl. 1) S113
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crooks, B., Taylor, C., Turner, A. et al. Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit. Bone Marrow Transplant 26, 1097–1102 (2000). https://doi.org/10.1038/sj.bmt.1702656
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bmt.1702656
Keywords
This article is cited by
-
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
Nature Communications (2024)
-
Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders
Current Allergy and Asthma Reports (2017)
-
Severe Combined Immunodeficiency in Serbia and Montenegro Between Years 1986 and 2010: A Single-Center Experience
Journal of Clinical Immunology (2014)
-
The Common Cold: Potential for Future Prevention or Cure
Current Allergy and Asthma Reports (2014)
-
Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient
International Journal of Hematology (2008)


